Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Iridex Cp (IRIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,346
  • Shares Outstanding, K 13,633
  • Annual Sales, $ 42,600 K
  • Annual Income, $ -12,810 K
  • 60-Month Beta 1.03
  • Price/Sales 1.59
  • Price/Cash Flow N/A
  • Price/Book 2.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.24
  • Number of Estimates 2
  • High Estimate -0.23
  • Low Estimate -0.25
  • Prior Year -0.31
  • Growth Rate Est. (year over year) +22.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.11 +25.55%
on 03/25/19
5.18 -0.39%
on 04/18/19
+0.73 (+16.48%)
since 03/18/19
3-Month
4.08 +26.47%
on 03/08/19
5.18 -0.39%
on 04/18/19
+0.37 (+7.72%)
since 01/18/19
52-Week
3.72 +38.71%
on 12/20/18
9.48 -45.57%
on 08/31/18
-0.49 (-8.67%)
since 04/18/18

Most Recent Stories

More News
IRIDEX to Report First Quarter 2019 Financial Results on May 2, 2019

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2019 after the close of trading on Thursday, May 2, 2019. The Company's management...

IRIX : 5.16 (+3.82%)
Ken Ludlum Appointed to IRIDEX Board of Directors

IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Ken Ludlum has been appointed...

IRIX : 5.16 (+3.82%)
MicroPulse TSCPC featured in multiple abstracts, posters, presentations and wet lab at the World Glaucoma Congress

IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its Cyclo G6(R) Glaucoma Laser...

IRIX : 5.16 (+3.82%)
Global Medical Laser Market Outlook to 2024 - Bausch & Lomb, Koninklijke Philips and IRIDEX Corporation are Dominating - ResearchAndMarkets.com

The "Medical Laser Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

IRIX : 5.16 (+3.82%)
IRIDEX to Present at the Spring Investor Summit

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY.

IRIX : 5.16 (+3.82%)
IRIDEX to Present at the 31st Annual Roth Conference

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming 31 Annual Roth Conference in Orange County, CA.

IRIX : 5.16 (+3.82%)
What's in Store for Upland Software's (UPLD) Q4 Earnings?

Upland Software's (UPLD) fourth-quarter 2018 results are expected to benefit from solid adoption of the UplandOne operating platform and recurring revenue growth.

MOMO : 35.67 (-1.03%)
UPLD : 40.03 (-1.60%)
TCEHY : 50.3700 (+0.20%)
IRIX : 5.16 (+3.82%)
IRIDEX Announces Resolution of its Dispute with Quantel Medical

IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. (collectively, "Quantel") in its lawsuit filed against...

IRIX : 5.16 (+3.82%)
QUTEF : 16.3561 (+1.72%)
IRIDEX Announces Preliminary Operational and Financial Results for 2018 Fourth Quarter and Full Year

IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 29, 2018.

IRIX : 5.16 (+3.82%)
Iridex: 1Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Thursday reported a loss of $3.6 million in its first quarter.

IRIX : 5.16 (+3.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IRIX with:

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

2nd Resistance Point 5.49
1st Resistance Point 5.33
Last Price 5.16
1st Support Level 4.85
2nd Support Level 4.53

See More

52-Week High 9.48
Fibonacci 61.8% 7.28
Fibonacci 50% 6.60
Fibonacci 38.2% 5.92
Last Price 5.16
52-Week Low 3.72

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar